Neulasta Market Report 2026
Download Free Sample Buy Now
Neulasta Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Neulasta Market Report 2026

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Neulasta Market Overview

• The Neulasta market growth in the historic period has been driven by expansion of chemotherapy usage, rising incidence of treatment-induced neutropenia

• Market expansion is supported by increasing demand for convenient drug delivery systems, rising investments in biosimilar competition

• Growth Driver: Rising Cancer Incidence To Drive Market Growth

• Market Trend: Innovative Drug Delivery Technologies In The Market

• North America was the largest region in 2025.

What Is Covered Under Neulasta Market?

Neulasta is a prescription medication designed to reduce the risk of infection in chemotherapy patients by boosting white blood cell production. It is administered as an injection, often using an on-body injector or prefilled syringe, and is recognized for managing neutropenia efficiently and conveniently.

The main indication types of neulasta are chemotherapy-induced neutropenia, bone marrow transplantation, and others. Chemotherapy-induced neutropenia is a condition where chemotherapy reduces neutrophil levels, a type of white blood cell crucial for fighting infections, increasing the risk of severe infections and complications during cancer treatment. The formulations are injectable solution and pre-filled syringes or pens and the distribution channel includes hospitals, oncology clinics, specialty pharmacies, and home healthcare services. It is used by various end users patients such as adult patients and pediatric patients.

Neulasta Market Global Report 2026 Market Report bar graph

What Is The Neulasta Market Size and Share 2026?

The growth in the historic period can be attributed to expansion of chemotherapy usage, rising incidence of treatment-induced neutropenia, availability of pegylated growth factors, increased oncology supportive care protocols, adoption of prefilled injection devices.

What Is The Neulasta Market Growth Forecast?

The growth in the forecast period can be attributed to increasing demand for convenient drug delivery systems, rising investments in biosimilar competition, expansion of home-based oncology treatments, growing focus on patient-centric cancer care, increasing adoption of long-acting biologics. Major trends in the forecast period include increasing adoption of long-acting neutropenia treatments, rising use of on-body injector systems, expansion of supportive oncology care, growing preference for outpatient cancer management, enhanced focus on treatment adherence.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Neulasta Market Segmentation

1) By Indication: Chemotherapy-Induced Neutropenia, Bone Marrow Transplantation, Other Indications

2) By Formulation: Injectable Solution, Pre-Filled Syringes Or Pens

3) By Distribution Channel: Hospitals, Oncology Clinics, Specialty Pharmacies, Home Healthcare Services

4) By End User Patients: Adult Patients, Pediatric Patients

What Are The Drivers Of The Neulasta Market?

The rising incidence of cancer is driving the growth of the neulasta market going forward. Cancer is a group of diseases characterized by abnormal cell growth, which can spread to other body parts. Cancer incidence is rising largely because populations are ageing, and the likelihood of developing cancer increases significantly as people live longer. Neulasta, a pegfilgrastim-based therapy, supports cancer care by preventing chemotherapy-induced neutropenia, stimulating white blood cell production, and reducing infection risks in patients undergoing chemotherapy. For instance, in August 2024, according to the Australian Institute of Health and Welfare, an Australia-based national agency for health statistics, Australia is projected to record approximately 209,000 new cancer cases by 2034, up from an estimated 169,000 cases in 2024, and cancer is expected to account for around three out of every ten deaths in 2024. Therefore, the rising incidence of cancer will drive the neulasta industry.

The growing adoption of personalized medicine is expected to propel the growth of the neulasta market going forward. Personalized medicine involves tailoring treatments to individual patient profiles, enhancing efficacy, and reducing side effects. The adoption of personalized medicine is driven by advancements in genomics and biotechnology, enabling tailored treatments that improve effectiveness and minimize side effects, alongside increasing demand for precision in managing complex diseases such as cancer and rare genetic disorders. Neulasta (pegfilgrastim) supports personalized medicine by effectively preventing chemotherapy-induced neutropenia through precise dosing and advanced delivery systems such as autoinjectors, aligning treatment with individual patient needs and chemotherapy regimens. For instance, in February 2024, according to Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the Food and Drug Administration (FDA), a US-based federal agency under the Department of Health and Human Services, approved 16 new personalized treatments for rare disease patients, up from 6 in 2022. The newly approved personalized treatments for 2023 include seven cancer drugs and three for other diseases and conditions. Therefore, the increasing adoption of personalized medicine will drive the neulasta industry.

Key Players In The Global Neulasta Market

Major companies operating in the neulasta market are Amgen Inc.

Global Neulasta Market Trends and Insights

The key trend in the neulasta market is the development of drug delivery technologies, such as prefilled autoinjectors, to gain a competitive edge in the industry. Prefilled autoinjectors are self-injection devices preloaded with medication, designed for convenient and easy patient self-administration. For example, in March 2023, Coherus Biosciences, a US-based biopharmaceutical company, announced that the FDA approved a single-dose, prefilled autoinjector version of its pegfilgrastim biosimilar, Udenyca (pegfilgrastim-cbqv), for the treatment and prevention of febrile neutropenia, a common complication of chemotherapy. This autoinjector allows patients to receive pegfilgrastim the day after chemotherapy, reducing the risk of febrile neutropenia. The device features push-on-skin activation for reliable, immediate delivery of a full pegfilgrastim dose.

Need data on a specific region in this market?
Request Regional Data

Regional Insights

North America was the largest region in the neulasta market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Neulasta Market?

The neulasta market consists of sales of prefilled syringes, injection devices, and biosimilar products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Neulasta Market Report 2026?

The neulasta market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the neulasta industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Neulasta Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate No CAGR found from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Indication, Formulation, Distribution Channel, End User Patients
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Amgen Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Neulasta Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Neulasta Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Neulasta Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Neulasta Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics And Precision Medicine

4.1.2 Industry 4.0 And Intelligent Manufacturing

4.1.3 Digitalization, Cloud, Big Data And Cybersecurity

4.1.4 Artificial Intelligence And Autonomous Intelligence

4.1.5 Sustainability, Climate Tech And Circular Economy

4.2. Major Trends

4.2.1 Increasing Adoption Of Long-Acting Neutropenia Treatments

4.2.2 Rising Use Of On-Body Injector Systems

4.2.3 Expansion Of Supportive Oncology Care

4.2.4 Growing Preference For Outpatient Cancer Management

4.2.5 Enhanced Focus On Treatment Adherence

5. Neulasta Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Oncology Clinics

5.3 Specialty Pharmacies

5.4 Home Healthcare Providers

5.5 Cancer Care Centers

6. Neulasta Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neulasta Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Neulasta PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Neulasta Market Size, Comparisons And Growth Rate Analysis

7.3. Global Neulasta Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Neulasta Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neulasta Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neulasta Market Segmentation

9.1. Global Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chemotherapy-Induced Neutropenia, Bone Marrow Transplantation, Other Indications

9.2. Global Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Injectable Solution, Pre-Filled Syringes Or Pens

9.3. Global Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Oncology Clinics, Specialty Pharmacies, Home Healthcare Services

9.4. Global Neulasta Market, Segmentation By End User Patients, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adult Patients, Pediatric Patients

10. Neulasta Market Regional And Country Analysis

10.1. Global Neulasta Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Neulasta Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neulasta Market

11.1. Asia-Pacific Neulasta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Neulasta Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neulasta Market

12.1. China Neulasta Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Neulasta Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neulasta Market

13.1. India Neulasta Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neulasta Market

14.1. Japan Neulasta Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Neulasta Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neulasta Market

15.1. Australia Neulasta Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Neulasta Market

16.1. South Korea Neulasta Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

16.2. South Korea Neulasta Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Neulasta Market

17.1. Western Europe Neulasta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. Western Europe Neulasta Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Neulasta Market

18.1. UK Neulasta Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Neulasta Market

19.1. Germany Neulasta Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Neulasta Market

20.1. France Neulasta Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Neulasta Market

21.1. Eastern Europe Neulasta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Eastern Europe Neulasta Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Neulasta Market

22.1. North America Neulasta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

22.2. North America Neulasta Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Neulasta Market

23.1. USA Neulasta Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

23.2. USA Neulasta Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Neulasta Market

24.1. Canada Neulasta Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

24.2. Canada Neulasta Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Neulasta Market

25.1. South America Neulasta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

25.2. South America Neulasta Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Neulasta Market

26.1. Middle East Neulasta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Middle East Neulasta Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Neulasta Market

27.1. Africa Neulasta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Africa Neulasta Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Neulasta Market Regulatory and Investment Landscape

29. Neulasta Market Competitive Landscape And Company Profiles

29.1. Neulasta Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Neulasta Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Neulasta Market Company Profiles

29.3.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

30. Global Neulasta Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Neulasta Market

32. Neulasta Market High Potential Countries, Segments and Strategies

32.1 Neulasta Market In 2030 - Countries Offering Most New Opportunities

32.2 Neulasta Market In 2030 - Segments Offering Most New Opportunities

32.3 Neulasta Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Neulasta Market, Overview Of Key Products - Product Examples
  • Table 2: Global Neulasta Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Neulasta Market, Supply Chain Analysis
  • Table 4: Global Neulasta Market, Major Raw Material Providers
  • Table 5: Global Neulasta Market, Major Resource Providers
  • Table 6: Global Neulasta Market, Major Manufacturers (Suppliers)
  • Table 7: Global Neulasta Market, Major Distributors And Channel Partners
  • Table 8: Global Neulasta Market, Key Technologies & Future Trends
  • Table 9: Global Neulasta Market, Major Trends
  • Table 10: Global Neulasta Market, Major End Users
  • Table 11: Global Neulasta Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Neulasta Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Neulasta Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Neulasta Market - TAM, US$ Billion, 2025
  • Table 15: Global Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Neulasta Market, Segmentation By End User Patients, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Neulasta Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Neulasta Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Asia-Pacific, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: China, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: India, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Japan, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Australia, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: South Korea, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: South Korea, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: South Korea, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Western Europe, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Western Europe, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Western Europe, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: UK, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: UK, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: UK, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Germany, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Germany, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Germany, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: France, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: France, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: France, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Eastern Europe, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Eastern Europe, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Eastern Europe, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: North America, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: North America, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: North America, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: USA, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: USA, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: USA, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Canada, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Canada, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Canada, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: South America, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: South America, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: South America, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Middle East, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Middle East, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Middle East, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Africa, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Africa, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Africa, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Global Neulasta Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 73: Global Neulasta Market - Company Scoring Matrix
  • Table 74: Amgen Inc. Financial Performance
  • Table 75: Global Neulasta Market, Competitive Benchmarking (In USD Billions)
  • Table 76: Global Neulasta Market, Competitive Dashboard
  • Table 77: Global Neulasta Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 78: Global, Neulasta Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 79: Global, Neulasta Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030
  • Table 80: Global, Neulasta Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

    Figure 1: Global Neulasta Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Neulasta Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Neulasta Market, Supply Chain Analysis
  • Figure 4: Global Neulasta Market, Major Raw Material Providers
  • Figure 5: Global Neulasta Market, Major Resource Providers
  • Figure 6: Global Neulasta Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Neulasta Market, Major Distributors And Channel Partners
  • Figure 8: Global Neulasta Market, Key Technologies & Future Trends
  • Figure 9: Global Neulasta Market, Major Trends
  • Figure 10: Global Neulasta Market, Major End Users
  • Figure 11: Global Neulasta Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Neulasta Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Neulasta Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Neulasta Market - TAM, US$ Billion, 2025
  • Figure 15: Global Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Neulasta Market, Segmentation By End User Patients, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Neulasta Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Neulasta Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Asia-Pacific, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: China, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: India, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Japan, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Australia, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: South Korea, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: South Korea, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: South Korea, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Western Europe, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Western Europe, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Western Europe, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: UK, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: UK, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: UK, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Germany, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Germany, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Germany, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: France, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: France, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: France, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Eastern Europe, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Eastern Europe, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Eastern Europe, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: North America, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: North America, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: North America, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: USA, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: USA, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: USA, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Canada, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Canada, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Canada, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: South America, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: South America, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: South America, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Middle East, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Middle East, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Middle East, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Africa, Neulasta Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Africa, Neulasta Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Africa, Neulasta Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Global Neulasta Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 73: Global Neulasta Market - Company Scoring Matrix
  • Figure 74: Amgen Inc. Financial Performance
  • Figure 75: Global Neulasta Market, Competitive Benchmarking (In USD Billions)
  • Figure 76: Global Neulasta Market, Competitive Dashboard
  • Figure 77: Global Neulasta Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 78: Global, Neulasta Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 79: Global, Neulasta Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030
  • Figure 80: Global, Neulasta Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Data Lake Market Report 2026 - Global Outlook – By Type (Solution, Services), By Deployment (On-Premise, Cloud), By Organization Size (Large Enterprises, Small And Medium-Sized Enterprises (SMEs)), By Vertical (Informati...

Nematicides Market Report 2026 - Global Outlook – By Type (Fumigants, Bio Nematicides, Organophosphates, Carbamates), By Form (Granular Or Powder, Liquid), By Crop Type (Fruits and Vegetables, Oilseeds, Cereals and Grain...

Trade Finance Market Report 2026 - Global Outlook – By Type (Supply Chain Finance, Structured Trade Finance, Traditional Trade Finance), By Service Provider (Banks, Financial Institutions, Trading Houses, Other Services)...

Membrane Filtration Market Report 2026 - Global Outlook – By Type (Reverse Osmosis, Ultrafiltration, Microfiltration, Nanofiltration), By Module Design (Spiral Wound, Tubular Systems, Plate & Frame, Hollow Fiber), By Mem...

Vertical Market Software Market Report 2026 - Global Outlook – By Software Type (Banking Software, Education Software, Legal Software, Agriculture Software, Alumni Management Software, Amusement Park Software, Apparel So...

Financial Analytics Market Report 2026 - Global Outlook – By Component (Solution, Services), By Deployment Mode (On-Premise, Cloud), By Organization Size (Large Enterprises, Small And Medium Sized Enterprises), By Applic...

Biopreservation Market Report 2026 - Global Outlook – By Type (Biopreservation Equipment, Biopreservation Media), By Biospecimen (Human Tissue Samples, Organs, Stem Cells, Other Biospecimens), By Application (Therapeutic...

Nebulizers Market 2022 - By Type (Pneumatic Nebulizer, Ultrasonic Nebulizer, Mesh Nebulizer), By Application (COPD, Cystic Fibrosis, Asthma), By End-Use (Hospitals And Clinics, Emergency Centres, Home Healthcare), By Por...

Frequently Asked Questions

The Neulasta market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

The global Neulasta market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Some Key Players in the Neulasta market Include, Amgen Inc. .

Major trend in this market includes: Innovative Drug Delivery Technologies In The Market. For further insights on this market. request a sample here

North America was the largest region in the neulasta market in 2025. The regions covered in the neulasta market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us